Please enable JavaScript to continue using this application.

Compare $NBP vs $TARA | Chartloom

Compare

$NBP vs $TARA

NovaBridge Biosciences · Protara Therapeutics Inc

NBP

NovaBridge Biosciences

TARA

Protara Therapeutics Inc

Compare $NBP vs $TARA

Comparing NovaBridge Biosciences and Protara Therapeutics Inc

NBPNovaBridge Biosciences

TARAProtara Therapeutics Inc

NBPNovaBridge Biosciences

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-72.5%

FCF yield

-33.9%

TARAProtara Therapeutics Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.8%

52W performance

-45.7%

FCF yield

-42.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NBP

TARA

Detailed metrics comparison

NBP

NovaBridge Biosciences

TARA

Protara Therapeutics Inc

Market Cap

NBP$161M

TARA$155M

Enterprise Value

NBP$-30M

TARA$138M

Price

NBP$1.40

TARA$2.76

P/E Ratio

NBPN/A

TARAN/A

P/S Ratio

NBP3.29x

TARA0.00x

EV/Sales

NBP0.00x

TARA0.00x

EV/EBITDA

NBP0.00x

TARA0.00x

P/B Ratio

NBP0.77x

TARA0.99x

P/FCF Ratio

NBPN/A

TARAN/A

EV/FCF

NBP0.55x

TARA-2.07x

PEG Ratio

NBPN/A

TARAN/A

Forward P/E (NTM)

NBPN/A

TARAN/A

Forward P/S (NTM)

NBPN/A

TARAN/A

Revenue (TTM)

NBP$0

TARA$0

Revenue Growth (YoY)

NBPN/A

TARAN/A

Forward Rev Growth

NBP419.8%

TARA5488.8%

Gross Margin (TTM)

NBP100.0%

TARA0.0%

Operating Margin (TTM)

NBP0.0%

TARA0.0%

EBITDA Margin (TTM)

NBP0.0%

TARA0.0%

Net Margin (TTM)

NBP0.0%

TARA0.0%

FCF Margin (TTM)

NBPN/A

TARAN/A

Net Income (TTM)

NBP$-43M

TARA$-70M

FCF (TTM)

NBP$-55M

TARA$-66M

EPS (TTM)

NBP$0.00

TARA-$1.15

ROE (TTM)

NBP-2091.0%

TARA-4172.0%

ROA (TTM)

NBP-1941.0%

TARA-3878.0%

ROIC (TTM)

NBP-2091.0%

TARA-4172.0%

Cash

NBP$191M

TARA$17M

Debt

NBP$0

TARA$0

Net Cash/Debt

NBP$191M

TARA$17M

Current Ratio (TTM)

NBP7.64x

TARA10.97x

Quick Ratio (TTM)

NBP7.60x

TARA10.81x

Debt/Equity (TTM)

NBP0.00x

TARA0.00x

Debt/Assets (TTM)

NBP0.0%

TARA0.0%

Interest Coverage (TTM)

NBPN/A

TARAN/A

Net Debt/EBITDA (TTM)

NBP0.00x

TARA0.00x

Beta

NBP1.69

TARA1.54

52W Performance

NBP-72.5%

TARA-45.7%

YTD Performance

NBP-67.3%

TARA-48.8%

% from 52W High

NBP-79.5%

TARA-64.8%

% from 52W Low

NBP6.5%

TARA9.8%

Asset Turnover (TTM)

NBP0.11x

TARA0.00x

FCF Yield (TTM)

NBP-33.9%

TARA-42.9%

Earnings Yield (TTM)

NBP-26.8%

TARA-45.2%

Dividend Yield (TTM)

NBPN/A

TARAN/A

Rule of 40

NBP0.0

TARA0.0

EV/GP/RG

NBPN/A

TARAN/A

Ticker research

View NBP research View TARA research

Metric	NBP NovaBridge Biosciences	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$161M	$155M
Enterprise Value	$-30M	$138M
Price	$1.40	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	3.29x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.77x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	419.8%	5488.8%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-70M
FCF (TTM)	$-55M	$-66M
EPS (TTM)	$0.00	-$1.15
ROE (TTM)	-2091.0%	-4172.0%
ROA (TTM)	-1941.0%	-3878.0%
ROIC (TTM)	-2091.0%	-4172.0%
Financial Health
Cash	$191M	$17M
Debt	$0	$0
Net Cash/Debt	$191M	$17M
Current Ratio (TTM)	7.64x	10.97x
Quick Ratio (TTM)	7.60x	10.81x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	1.54
52W Performance	-72.5%	-45.7%
YTD Performance	-67.3%	-48.8%
% from 52W High	-79.5%	-64.8%
% from 52W Low	6.5%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-33.9%	-42.9%
Earnings Yield (TTM)	-26.8%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NBP research	View TARA research

Valuation

P/S Ratio

TARA

0.00x

NBP

3.29x

EV/FCF

TARA

-2.07x

NBP

0.55x

Growth & revenue

Forward Revenue Growth

TARA

5488.8%

NBP

419.8%

Profitability & performance

Gross Margin

NBP

100.0%

TARA

0.0%

ROE

NBP

-2091.0%

TARA

-4172.0%

FCF Yield %

NBP

-33.9%

TARA

-42.9%

52-Week Performance

TARA

-45.7%

NBP

-72.5%

Detailed metrics comparison

NBP

NovaBridge Biosciences

TARA

Protara Therapeutics Inc

Market Cap

NBP$161M

TARA$155M

Enterprise Value

NBP$-30M

TARA$138M

Price

NBP$1.40

TARA$2.76

P/E Ratio

NBPN/A

TARAN/A

P/S Ratio

NBP3.29x

TARA0.00x

EV/Sales

NBP0.00x

TARA0.00x

EV/EBITDA

NBP0.00x

TARA0.00x

P/B Ratio

NBP0.77x

TARA0.99x

P/FCF Ratio

NBPN/A

TARAN/A

EV/FCF

NBP0.55x

TARA-2.07x

PEG Ratio

NBPN/A

TARAN/A

Forward P/E (NTM)

NBPN/A

TARAN/A

Forward P/S (NTM)

NBPN/A

TARAN/A

Revenue (TTM)

NBP$0

TARA$0

Revenue Growth (YoY)

NBPN/A

TARAN/A

Forward Rev Growth

NBP419.8%

TARA5488.8%

Gross Margin (TTM)

NBP100.0%

TARA0.0%

Operating Margin (TTM)

NBP0.0%

TARA0.0%

EBITDA Margin (TTM)

NBP0.0%

TARA0.0%

Net Margin (TTM)

NBP0.0%

TARA0.0%

FCF Margin (TTM)

NBPN/A

TARAN/A

Net Income (TTM)

NBP$-43M

TARA$-70M

FCF (TTM)

NBP$-55M

TARA$-66M

EPS (TTM)

NBP$0.00

TARA-$1.15

ROE (TTM)

NBP-2091.0%

TARA-4172.0%

ROA (TTM)

NBP-1941.0%

TARA-3878.0%

ROIC (TTM)

NBP-2091.0%

TARA-4172.0%

Cash

NBP$191M

TARA$17M

Debt

NBP$0

TARA$0

Net Cash/Debt

NBP$191M

TARA$17M

Current Ratio (TTM)

NBP7.64x

TARA10.97x

Quick Ratio (TTM)

NBP7.60x

TARA10.81x

Debt/Equity (TTM)

NBP0.00x

TARA0.00x

Debt/Assets (TTM)

NBP0.0%

TARA0.0%

Interest Coverage (TTM)

NBPN/A

TARAN/A

Net Debt/EBITDA (TTM)

NBP0.00x

TARA0.00x

Beta

NBP1.69

TARA1.54

52W Performance

NBP-72.5%

TARA-45.7%

YTD Performance

NBP-67.3%

TARA-48.8%

% from 52W High

NBP-79.5%

TARA-64.8%

% from 52W Low

NBP6.5%

TARA9.8%

Asset Turnover (TTM)

NBP0.11x

TARA0.00x

FCF Yield (TTM)

NBP-33.9%

TARA-42.9%

Earnings Yield (TTM)

NBP-26.8%

TARA-45.2%

Dividend Yield (TTM)

NBPN/A

TARAN/A

Rule of 40

NBP0.0

TARA0.0

EV/GP/RG

NBPN/A

TARAN/A

Ticker research

View NBP research View TARA research

Metric	NBP NovaBridge Biosciences	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$161M	$155M
Enterprise Value	$-30M	$138M
Price	$1.40	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	3.29x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.77x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	419.8%	5488.8%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-70M
FCF (TTM)	$-55M	$-66M
EPS (TTM)	$0.00	-$1.15
ROE (TTM)	-2091.0%	-4172.0%
ROA (TTM)	-1941.0%	-3878.0%
ROIC (TTM)	-2091.0%	-4172.0%
Financial Health
Cash	$191M	$17M
Debt	$0	$0
Net Cash/Debt	$191M	$17M
Current Ratio (TTM)	7.64x	10.97x
Quick Ratio (TTM)	7.60x	10.81x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	1.54
52W Performance	-72.5%	-45.7%
YTD Performance	-67.3%	-48.8%
% from 52W High	-79.5%	-64.8%
% from 52W Low	6.5%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-33.9%	-42.9%
Earnings Yield (TTM)	-26.8%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NBP research	View TARA research